erastin - Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Columbia University, Prolexys
Modified Qianghuo Shengshi Decoction Ameliorates Osteoarthritis via Inhibiting PI3K/Akt Pathway-Related Ferroptosis. (PubMed, J Cell Mol Med) - Jul 1, 2025 - "Network pharmacology was utilised to pinpoint disease targets, while various assays assessed ferroptosis-related chondrocyte phenotypes under Erastin or Ferrostatin-1 treatments...Molecular docking studies affirm the strong interaction between MQSD's key ingredients and the PI3K/Akt/GPX4 pathway components. Through modulation of ferroptosis via the PI3K/Akt pathway, MQSD retards OA progression." 
Journal • Immunology • Osteoarthritis • Pain • Rheumatology • ANXA5 • GPX4 • IL1B
http://www.ncbi.nlm.nih.gov/pubmed/40586853
 
Chen Zhuang; Chenxuan Hong; Enli Li; Lei Yang; Wen-Kai Li; Xiaojuan Geng; Yu Pan
 
Jul 1, 2025
 
Prev Next